Jennifer Ling Lee

Insider

First SEC filing: Dec. 7, 2018 · Latest: Dec. 7, 2018

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Initial holdings The stakes this person held when they first started reporting.

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 30 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

30 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
March 9, 2020	MRNA	S	361	$27.33	$9,866	4,419 Direct	-7.55%	Disposed	423.6% (price as of 2026-08-21)
Feb. 28, 2020	MRNA	A	8,677	—	—	8,677 Direct	—	Acquired	(price as of 2026-08-21)
Feb. 28, 2020	MRNA	A	16,112	—	—	16,112 Direct	—	Acquired	(price as of 2026-08-21)
March 8, 2019	MRNA	A	25,097	—	—	25,097 Direct	—	Acquired	(price as of 2026-08-21)
March 8, 2019	MRNA	A	4,780	—	—	4,780 Direct	—	Acquired	(price as of 2026-08-21)
Feb. 20, 2018	LAB	M	1,125	—	—	13,126 Direct	-7.89%	Disposed	(price as of 2026-08-21)
Feb. 20, 2018	LAB	M	630	—	—	5,670 Direct	-10.00%	Disposed	(price as of 2026-08-21)
Feb. 20, 2018	LAB	F	716	$7.81	$5,592	6,716 Direct	-9.63%	Disposed	-91.9% (price as of 2026-08-21)
Feb. 20, 2018	LAB	M	1,125	—	—	7,432 Direct	+17.84%	Acquired	(price as of 2026-08-21)
Feb. 20, 2018	LAB	M	630	—	—	6,307 Direct	+11.10%	Acquired	(price as of 2026-08-21)
Nov. 20, 2017	LAB	M	1,125	—	—	14,251 Direct	-7.32%	Disposed	(price as of 2026-08-21)
Nov. 20, 2017	LAB	M	630	—	—	6,300 Direct	-9.09%	Disposed	(price as of 2026-08-21)
Nov. 20, 2017	LAB	F	660	$5.19	$3,425	4,524 Direct	-12.73%	Disposed	-87.9% (price as of 2026-08-21)
Nov. 20, 2017	LAB	M	1,125	—	—	5,184 Direct	+27.72%	Acquired	(price as of 2026-08-21)
Nov. 20, 2017	LAB	M	630	—	—	4,059 Direct	+18.37%	Acquired	(price as of 2026-08-21)
Sept. 20, 2017	LAB	A	7,053	—	—	7,053 Direct	—	Acquired	(price as of 2026-08-21)
Sept. 20, 2017	LAB	D	13,400	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-21)
Aug. 21, 2017	LAB	M	1,125	—	—	15,376 Direct	-6.82%	Disposed	(price as of 2026-08-21)
Aug. 21, 2017	LAB	M	630	—	—	6,930 Direct	-8.33%	Disposed	(price as of 2026-08-21)
Aug. 21, 2017	LAB	F	660	$3.76	$2,482	3,429 Direct	-16.14%	Disposed	-83.2% (price as of 2026-08-21)
Aug. 21, 2017	LAB	M	1,125	—	—	4,089 Direct	+37.96%	Acquired	(price as of 2026-08-21)
Aug. 21, 2017	LAB	M	630	—	—	2,964 Direct	+26.99%	Acquired	(price as of 2026-08-21)
May 22, 2017	LAB	M	1,499	—	—	16,501 Direct	-8.33%	Disposed	(price as of 2026-08-21)
May 22, 2017	LAB	M	2,520	—	—	7,560 Direct	-25.00%	Disposed	(price as of 2026-08-21)
May 22, 2017	LAB	F	1,685	$5.46	$9,200	2,334 Direct	-41.93%	Disposed	-88.5% (price as of 2026-08-21)
May 22, 2017	LAB	M	1,499	—	—	4,019 Direct	+59.48%	Acquired	(price as of 2026-08-21)
May 22, 2017	LAB	M	2,520	—	—	2,520 Direct	—	Acquired	(price as of 2026-08-21)
Feb. 13, 2017	LAB	A	45,400	—	—	45,400 Direct	—	Acquired	(price as of 2026-08-21)
Feb. 13, 2017	LAB	A	18,000	—	—	18,000 Direct	—	Acquired	(price as of 2026-08-21)
May 18, 2016	LAB	A	13,400	—	—	13,400 Direct	—	Acquired	(price as of 2026-08-21)
May 18, 2016	LAB	A	10,080	—	—	10,080 Direct	—	Acquired	(price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Feb. 28, 2020	MRNA	Restricted Stock Units	Common Stock (8,677)	$0.00	—	8,677	Acquired
Feb. 28, 2020	MRNA	Stock Option (Right to Buy)	Common Stock (16,112)	$25.93	Feb. 28, 2030	16,112	Acquired
March 8, 2019	MRNA	Stock Option (Right to Buy)	Common Stock (25,097)	$20.93	March 8, 2029	25,097	Acquired
Feb. 20, 2018	LAB	Restricted Stock Units	Common Stock (1,125)	—	—	1,125	Disposed
Feb. 20, 2018	LAB	Restricted Stock Units	Common Stock (630)	—	—	630	Disposed
Nov. 20, 2017	LAB	Restricted Stock Units	Common Stock (1,125)	—	—	1,125	Disposed
Nov. 20, 2017	LAB	Restricted Stock Units	Common Stock (630)	—	—	630	Disposed
Sept. 20, 2017	LAB	Employee Stock Option (Right to Buy)	Common Stock (7,053)	$5.13	Sept. 20, 2027	7,053	Acquired
Sept. 20, 2017	LAB	Employee Stock Option (Right to Buy)	Common Stock (13,400)	$8.98	May 18, 2026	13,400	Disposed
Aug. 21, 2017	LAB	Restricted Stock Units	Common Stock (1,125)	—	—	1,125	Disposed
Aug. 21, 2017	LAB	Restricted Stock Units	Common Stock (630)	—	—	630	Disposed
May 22, 2017	LAB	Restricted Stock Units	Common Stock (1,499)	—	—	1,499	Disposed
May 22, 2017	LAB	Restricted Stock Units	Common Stock (2,520)	—	—	2,520	Disposed
Feb. 13, 2017	LAB	Stock Option (Right to Buy)	Common Stock (45,400)	$6.16	Feb. 13, 2027	45,400	Acquired
Feb. 13, 2017	LAB	Restricted Stock Units	Common Stock (18,000)	—	—	18,000	Acquired
May 18, 2016	LAB	Employee Stock Option (Right to Buy)	Common Stock (13,400)	$8.98	May 18, 2026	13,400	Acquired
May 18, 2016	LAB	Restricted Stock Units	Common Stock (10,080)	—	—	10,080	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Dec. 7, 2018	MRNA	Stock Option (Right to Buy)→ Common Stock (50,458)	50,458	Direct